$2.65
+
$0.13 (5.16%)
End-of-day quote: 05/01/2024
NasdaqGM:CVAC
CureVac N.V. Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $574.99 | $591.94 | 0.00% | 1 | $219.48B |
| DHR | Danaher | NYSE | Outperform | $246.89 | $260.33 | 0.00% | 4 | $182.87B |
| PFE | Pfizer | NYSE | Outperform | $27.18 | $32.87 | 0.00% | 6 | $153.91B |
| SAN | Sanofi | ENXTPA | Outperform | 93.08€ | 102.80€ | 0.00% | 9 | 116.22€B |
| GSK | GSK | LSE | Outperform | £17.05 | £17.30 | 0.00% | 12 | £69.53B |
| MRNA | Moderna | NasdaqGS | Outperform | $111.46 | $135.42 | 0.00% | 1 | $42.68B |
| BNTX | BioNTech | NasdaqGS | Outperform | $89.95 | $123.75 | 0.00% | 3 | $21.68B |
| 1548 | Genscript Biotech | SEHK | Buy | HK$11.64 | HK$3.96 | 0.00% | 0 | HK$24.72B |
| TWST | Twist Bioscience | NasdaqGS | Outperform | $31.96 | $34.00 | 0.00% | 2 | $1.81B |
